Fosifloxuridine nafalbenamide|1332837-31-6|(NUC-3373)-陌孚医药/Medlife

您当前的位置：

Fosifloxuridine nafalbenamide (Synonyms: NUC-3373)

目录号: PL11896 纯度: ≥98%

CAS No. :1332837-31-6

商品编号	规格	价格	会员价
PL11896-5mg	5mg	¥4098.00	请登录
PL11896-10mg	10mg	¥5946.00	请登录
PL11896-25mg	25mg	¥11893.00	请登录
PL11896-50mg	50mg	¥18001.00	请登录
PL11896-100mg	100mg	¥27002.00	请登录
PL11896-200mg	200mg	询价	询价
PL11896-500mg	500mg	询价	询价
PL11896-10mM*1mLinDMSO	10mM*1mLinDMSO	¥5532.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Fosifloxuridine nafalbenamide
英文名称	Fosifloxuridine nafalbenamide
英文别名	Fosifloxuridine nafalbenamide;DB14859;J3.616.613D;L-Alanine, N-(-2'-deoxy-2',2'-difluoro-p-1-naphthalenyl-5'-cytidylyl)-, phenylmethyl ester
Cas No.	1332837-31-6
分子式	C₂₉H₂₉FN₃O₉P
分子量	613.53
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情

Fosifloxuridine nafalbenamide (NUC-3373) 属于嘧啶核苷酸类似物，是一种胸腺嘧啶合酶 (Thymidylate synthase) 抑制剂。Fosifloxuridine nafalbenamide 具有抗癌活性。Fosifloxuridine nafalbenamide 具有诱发宿主免疫反应和增强免疫治疗的潜力。

生物活性

Fosifloxuridine nafalbenamide (NUC-3373), a pyrimidine nucleotide analogue, is a Thymidylate synthase inhibitor. Fosifloxuridine nafalbenamide has anticancer activity. Fosifloxuridine nafalbenamide has the potential to evoke a host immune response and enhance immunotherapy.

性状

Solid

体外研究(In Vitro)

Fosifloxuridine nafalbenamide induces the release of damage-associated molecular patterns (DAMPs), with increased expression of calreticulin (CRT) at the cell surface and concomitant loss of nuclear nuclear high mobility group box protein 1 (HMGB1).
has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Fosifloxuridine nafalbenamide exhibits anti-cancer activity in HT-29 nude mouse xenograft models.
has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder -20°C 3 years；4°C 2 years

ClinicalTrial

参考文献

[1]. Fiona G. McKissock, et al. Abstract 1848: NUC-3373 induces ER stress and the release of damage associated molecular patterns in colorectal cancer cells. Cancer Res August 15 2020 (80) (16 Supplement) 1848.
[2]. Essam A. Ghazaly, et al. Abstract B46: NUC-3373: A novel pyrimidine nucleotide analogue that overcomes key cancer drug resistance limiting patient survival. Mol Cancer Ther December 1 2015 (14) (12 Supplement 2) B46.

溶解度数据	In Vitro: DMSO : 100 mg/mL (162.99 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation